Is Boeing's Recovery Creating a New Multi-Year Growth Opportunity?

Boeing delivered 171 commercial aircraft in Q2 and began transitioning 737 output toward 47 aircraft per month in July, signaling improving execution and greater backlog conversion potential. Growth catalysts include FAA-approved 777X certification flight testing, initial 787 deliveries to Riyadh Air, and low-rate production progress for the MQ-25A and T-7A defense programs. Global Services generated $5.3 billion of Q2 revenue with a $33 billion backlog; consensus projects EPS growth of 91.45% in 2026 and 525.72% in 2027, while BA trades at 1.44x forward sales versus the industry's 2.26x.

Analysis

The investable question is not whether BA can increase output, but whether each incremental delivery converts into cash rather than working-capital absorption, supplier expediting costs, and customer concessions. BA’s equity remains a high-beta execution option: a sustained improvement in delivery cadence over the next 1-3 quarters could drive disproportionate free-cash-flow estimate revisions and deleveraging, while another quality incident would immediately reintroduce regulatory and balance-sheet risk. The stated valuation discount is therefore deserved unless quarterly cash conversion—not production targets—improves.

GE is the cleaner way to express the commercial-cycle upside. Engine OEM economics benefit from both new-build volumes and an expanding installed base, with higher-margin shop visits generally lagging aircraft deliveries by several years; this makes GE less exposed than BA to final-assembly disruption and certification risk. Airbus/AIR is also a relative winner if BA’s ramp remains uneven, as airline fleet planning values delivery reliability and constrained narrowbody slots preserve pricing power across the duopoly.

The consensus may be over-crediting the defense pipeline as a near-term earnings offset. Early production phases on fixed-price development-heavy programs can consume cash before margins normalize, and defense awards do not solve commercial quality costs. Over 6-18 months, the more important structural outcome is supplier capacity: aerospace suppliers with sole-source content and aftermarket exposure can gain pricing leverage, whereas financially weak tier-two suppliers remain a bottleneck that can cap BA’s volume upside.

Key Decisions for Investors

• Prefer long GE over BA for a 6-18 month commercial-aerospace recovery exposure; use BA as the short leg only if seeking a relative-value pair. Thesis is GE’s superior aftermarket mix and lower certification/liability tail risk; reassess if GE shop-visit or LEAP aftermarket guidance is cut.
• Maintain BA as a tactical, not core, long into the next two delivery/cash-flow reports only if monthly delivery data sustain the higher run-rate. Size for event risk; exit on an FAA production restriction, a material delivery shortfall, or another downward free-cash-flow revision. Upside requires cash conversion to validate multiple expansion.
• For a relative airline-manufacturer expression over 3-6 months, long AIR/short BA is preferable if evidence emerges that BA’s delivery schedule remains volatile. Cover if BA demonstrates two consecutive quarters of stable deliveries, improving inventory, and positive free cash flow.
• Monitor Spirit AeroSystems (SPR), Hexcel (HXL), and Howmet (HWM) as supply-chain read-throughs rather than initiating solely on this article. A widening gap between BA production aspirations and supplier shipment/working-capital commentary would falsify the ramp thesis before BA reports.
• No action in QBTS: it has no fundamental linkage to the aerospace execution mechanism and should not be included in a thematic basket.